Welcome
to our newest poster!
Devmab: Improving in-silico developability assessment for monoclonal antibodies
Identification of relevant analytical methods for adeno-associated
virus stability assessment during formulation development
Relevance for Biotech
and
Biopharma Professionals
Novel Analytical Framework
This study presents a first-of-its-kindsystematic
classification of analytical
methods based on their ability
to predict or indicate AAV stability—offering
a more rational and efficient approach
to formulation development.
Solving a Critical Development Bottleneck
By identifying tools that directly assess viralstability, the study supports
improved formulation strategies
that could reduce the need for deep-freeze
storage and enhance overall
manufacturing scalability.
Actionable Guidance for R&D Teams
The findings provide practical direction
on selecting analytical techniques best
suited for high-throughput formulation
screening, helping streamline early
development and reduce material
consumption.
Broad Applicability Across Modalities
While centered on AAVs, the methodologyand insights extend to other
viral vector platforms used in gene therapy,
vaccine development, and
oncolytic research—making the study
relevant across a wide range of therapeutic
areas.